Bronstein, Gewirtz & Grossman, LLC Notifies Fate Therapeutics, Inc. (FATE) Investors of Class Action and to Actively ParticipatePRNewsWire • 02/01/23
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Fate Therapeutics, Inc. (FATE) Investors to Filing of Securities Fraud Class Action, Encourages Investors with Significant Losses to Contact Firm's AttorneysNewsfile Corp • 01/31/23
Fate Class Action: Levi & Korsinsky Reminds Fate Therapeutics, Inc. Investors of The Pending Class Action Lawsuit With a Lead Plaintiff Deadline of March 22, 2023 - FATENewsfile Corp • 01/31/23
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 01/31/23
NOTICE: Investors in Fate Therapeutics, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – FATEBusiness Wire • 01/30/23
ROSEN, A LEADING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATEPRNewsWire • 01/30/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 01/30/23
INVESTOR NOTICE: Fate Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FATEPRNewsWire • 01/28/23
ROSEN, A LEADING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATENewsfile Corp • 01/27/23
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 01/27/23
FATE INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action FiledNewsfile Corp • 01/26/23
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 01/26/23
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fate Therapeutics, Inc. (FATE)Business Wire • 01/26/23
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 01/25/23
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fate Therapeutics, Inc. (FATE)Business Wire • 01/25/23
INVESTOR NOTICE: Fate Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Fate Therapeutics Class Action Lawsuit – FATEBusiness Wire • 01/25/23
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 01/25/23
INVESTOR DEADLINE: Fate Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FATENewsfile Corp • 01/25/23
ROSEN, A LEADING AND RANKED FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATEPRNewsWire • 01/24/23
FATE LAWSUIT: Hagens Berman, National Trial Attorneys, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action FiledNewsfile Corp • 01/24/23
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Fate Therapeutics, Inc. (FATE)Business Wire • 01/24/23
FATE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Fate Therapeutics, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 01/24/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Fate Therapeutics, Inc. (FATE) InvestorsBusiness Wire • 01/23/23
